Prolactin and estrogen up-regulate carboxypeptidase-D to promote nitric oxide production and survival of MCF-7 breast cancer cells

Endocrinology

Volumn 149, Issue 10, 2008, Pages 4821-4828

  Abdelmagid, Salma A ^a   Too, Catherine K L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 GUANIDINOETHYLTHIO) 2 (MERCAPTOMETHYL)PROPIONIC ACID; 4,5 DIAMINOFLUORESCEIN DIACETATE; AMINO ACID; ARGININE; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE D; CARBOXYPEPTIDASE M; DIETHYLAMINE; ESTRADIOL; FURYLACRYLOYLALANYLARININE; LIPOCORTIN 5; NITRIC OXIDE; PROLACTIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION;

3-MERCAPTOPROPIONIC ACID; APOPTOSIS; ARGININE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DIPEPTIDES; ESTRADIOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NITRIC OXIDE; PROLACTIN; PROTEASE INHIBITORS; PROTEINS; RNA, MESSENGER; TRANSFECTION; UP-REGULATION;

EID: 53249142426     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0145     Document Type: Article

References (45)

1. Skidgel RA, Erdos EG 1998 Cellular carboxypeptidases. Immunol Rev 161:129-141
2. Song L, Fricker LD 1995 Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 270:25007-25013
3. Song L, Fricker LD 1996 Tissue distribution and characterization of soluble and membrane-bound forms of metallocarboxypeptidase D. J Biol Chem 271:28884-28889
4. Varlamov O, Fricker LD 1998 Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface. J Cell Sci 111(Pt 7):877-885
5. Novikova EG, Eng FJ, Yan L, Qian Y, Fricker LD 1999 Characterization of the enzymatic properties of the first and second domains of metallocarboxypeptidase D. J Biol Chem 274:28887-28892
6. Varlamov O, Eng FJ, Novikova EG, Fricker LD 1999 Localization of metallocarboxypeptidase D in AtT-20 cells. Potential role in prohormone processing. J Biol Chem 274:14759-14767
7. Kalinina E, Varlamov O, Fricker LD 2002 Analysis of the carboxypeptidase D cytoplasmic domain: implications in intracellular trafficking. J Cell Biochem 85:101-111
8. Hadkar V, Skidgel RA 2001 Carboxypeptidase D is up-regulated in raw 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. Mol Pharmacol 59:1324-1332
9. Hadkar V, Sangsree S, Vogel SM, Brovkovych V, Skidgel RA 2004 Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 287:L35-L45
10. Nathan C, Xie QW 1994 Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918
11. Beckman JS, Koppenol WH 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437
12. Thomsen LL, Miles DW 1998 Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 17:107-118
13. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK 1999 Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 81:889-896
14. Jadeski LC, Lala PK 1999 Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 155:1381-1390
15. Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M 2005 The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur J Cancer 41:265-271
16. Lahiri M, Martin JH 2004 Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line. Oncol Rep 12:1007-1011
17. Loibl S, Bratengeier J, Farines V, von Minckwitz G, Spankuch B, Schini-Kerth V, Nepveu F, Strebhardt K, Kaufmann M 2006 Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS. Pathol Res Pract 202:1-7
18. Murphy PR, Limoges M, Dodd F, Boudreau RTM, Too CKL 2001 Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. Endocrinology 142:81-88
19. O'Malley PG, Sangster SM, Abdelmagid SA, Bearne SL, Too CKL 2005 Characterization of a novel, cytokine-inducible carboxypeptidase D isoform in haematopoietic tumour cells. Biochem J 390:665-673
20. Dodd F, Limoges M, Boudreau RTM, Rowden G, Murphy PR, Too CKL 2000 L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells. J Cell Biochem 77:624-634
21. Kelly PA, Ali S, Rozakis-Adcock M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J, Edery M, Finidori J, Postel-Vinay MC 1993 The growth hormone/prolactin receptor family. Recent Prog Horm Res 48:123-164
22. Shiu RP, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B 1987 Biological actions of prolactin in human breast cancer. Recent Prog Horm Res 43:277-303
23. Ginsburg E, Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591-2595
24. Reynolds C, Montone KT, Powell CM, Tomaszewski JE, Clevenger CV 1997 Expression of prolactin and its receptor in human breast carcinoma. Endocrinology 138:5555-5560
25. Clevenger CV, Furth PA, Hankinson SE, Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
26. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91:629-634
27. Prall OW, Rogan EM, Sutherland RL 1998 Estrogen regulation of cell cycle progression in breast cancer cells. J Steroid Biochem Mol Biol 65:169-174
28. Simpson ER, Misso M, Hewitt KN, Hill RA, Boon WC, Jones ME, Kovacic A, Zhou J, Clyne CD 2005 Estrogen - the good, the bad, and the unexpected. Endocr Rev 26:322-330
29. Herynk MH, Fuqua SA 2004 Estrogen receptor mutations in human disease. Endocr Rev 25:869-898
30. Dolinska M, Albrecht J 1998 L-arginine uptake in rat cerebral mitochondria. Neurochem Int 33:233-236
31. Kelly PA, Djiane J, Postel-Vinay MC, Edery M 1991 The prolactin/growth hormone receptor family. Endocr Rev 12:235-251
32. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
33. Migliaccio A, Pagano M, Auricchio F 1993 Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 8:2183-2191
34. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
35. Cabodi S, Moro L, Baj G, Smeriglio M, Di Stefano P, Gippone S, Surico N, Silengo L, Turco E, Tarone G, Defilippi P 2004 p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci 117:1603-1611
36. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20:6050-6059
37. Wang Y, Cheng CH 2004 ERα and STAT5a cross-talk: interaction through C-terminal portions of the proteins decreases STAT5a phosphorylation, nuclear translocation and DNA-binding. FEBS Lett 572:238-244
38. Sangsree S, Brovkovych V, Minshall RD, Skidgel RA 2003 Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am J Physiol Heart Circ Physiol 284:H1959-H1968
39. Pance A 2006 Nitric oxide and hormones in breast cancer: allies or enemies? Future Oncol 2:275-288
40. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ 1995 Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181:1333-1343
41. Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF 1999 Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest 79:1215-1225
42. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB 1995 Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 55:5272-5275
43. Mortensen K, Skouv J, Hougaard DM, Larsson LI 1999 Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 274:37679-37684
44. Kurz S, Harrison DG 1997 Insulin and the arginine paradox. J Clin Invest 99:369-370
45. McDonald KK, Zharikov S, Block ER, Kilberg MS 1997 A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272:31213-31216